Dihydromyricetin resists inflammation‐induced muscle atrophy via ryanodine receptor‐CaMKK‐AMPK signal pathway
Open Access
- 22 October 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (21) , 9953-9971
Abstract
Skeletal muscle plays a pivotal role in the maintenance of physical and metabolic health. Skeletal muscle atrophy usually results in physical disability, inferior quality of life and higher health care costs. The higher incidence of muscle atrophy in obese and ageing groups is due to increased levels of inflammatory factors during obesity and ageing. Dihydromyricetin, as a bioactive polyphenol, has been used for anti‐inflammatory, anti‐tumour and improving insulin sensitivity. However, there are no published reports demonstrated the dihydromyricetin effect on inflammation‐induced skeletal muscle atrophy. In this study, we first confirmed the role of dihydromyricetin in inflammation‐induced skeletal muscle atrophy in vivo and in vitro. Then, we demonstrated that dihydromyricetin resisted inflammation‐induced skeletal muscle atrophy by activating Ca2+‐CaMKK‐AMPK through signal pathway blockers, Ca2+ probes and immunofluorescence. Finally, we clarified that dihydromyricetin activated Ca2+‐CaMKK‐AMPK signalling pathway through interaction with the ryanodine receptor, its target protein, by drug affinity responsive target stability (DARTS). Our results not only demonstrated that dihydromyricetin resisted inflammation‐induced muscle atrophy via the ryanodine receptor‐CaMKK‐AMPK signal pathway but also discovered that the target protein of dihydromyricetin is the ryanodine receptor. Our results provided experimental data for the development of dihydromyricetin as a functional food and new therapeutic strategies for treating or preventing skeletal muscle atrophy.Keywords
This publication has 44 references indexed in Scilit:
- Target Identification Using Drug Affinity Responsive Target Stability (DARTS)Current Protocols in Chemical Biology, 2011
- Elevated NF-κB Activation Is Conserved in Human Myocytes Cultured From Obese Type 2 Diabetic Patients and Attenuated by AMP-Activated Protein KinaseDiabetes, 2011
- Type 2 diabetes as an inflammatory diseaseNature Reviews Immunology, 2011
- NF-κB, Inflammation, and Metabolic DiseaseCell Metabolism, 2011
- Obesity, metabolic syndrome and sleep apnoea: all pro‐inflammatory statesObesity Reviews, 2006
- Signaling Pathways in Skeletal Muscle RemodelingAnnual Review of Biochemistry, 2006
- Metabolic SyndromeCirculation, 2005
- IKKβ/NF-κB Activation Causes Severe Muscle Wasting in MiceCell, 2004
- Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle AtrophyCell, 2004
- Identification of Ubiquitin Ligases Required for Skeletal Muscle AtrophyScience, 2001